Akhil Maheshwari — MDRPedia
Akhil Maheshwari
Top 3% — Master Top 100 (#8)

Akhil Maheshwari

Neonatology · Pediatric Gastroenterology

Boston, Massachusetts, United States

69 H-Index
5,000 Lives Saved
25 Years Active
5,773 Total Impact

Overview

Akhil Maheshwari is a neonatology specialist with an H-index of 69 at Boston Children's Health Physicians (Director of Neonatology). Known for pioneered Cytokine therapies for NEC, Macrophage phenotype identification and impacted an estimated 5,000 lives. Has been published in JAMA Pediatrics. Based in Boston, Massachusetts, United States.

For Patients

  • Practicing pediatric gastroenterology specialist with 25+ years of experience
  • Pioneered 2 medical techniques including Cytokine therapies for NEC and Macrophage phenotype identification
  • Has impacted an estimated 5K+ lives through clinical work and research
  • Currently at Boston Children's Health Physicians in Boston, United States

Biography

Executive Summary

Dr. Akhil Maheshwari is an internationally acclaimed Neonatologist and physician-scientist, currently serving as the Director of Neonatology at Boston Children’s Health Physicians (BCHP). Renowned for his groundbreaking research into intestinal inflammation and Necrotizing Enterocolitis (NEC), Dr. Maheshwari's work has redefined our understanding of neonatal gut immunity. He has held prestigious leadership positions at Johns Hopkins and the University of South Florida.

Early Life and Education

Dr. Maheshwari earned his medical degree from Banaras Hindu University (BHU), Varanasi, followed by an MD in Pediatrics from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. He pursued advanced fellowships in Neonatal-Perinatal Medicine at the University of Florida, where he began his lifelong research into the developmental biology of the neonatal intestine.

Professional Career

Prior to his current role at Boston Children's, Dr. Maheshwari was the Pamela and Leslie Muma Endowed Chair in Neonatology at the University of South Florida and the Chief of Neonatology at Johns Hopkins All Children’s Hospital. His career is marked by a seamless integration of high-acuity clinical care and NIH-funded bench research.

Key Contributions & Innovations

  • TGF-β in Gut Health: Discovered the critical role of Transforming Growth Factor-beta (TGF-β) in suppressing macrophage activation in the developing intestine, a mechanism often failing in NEC.
  • Macrophage Biology: Identified specific macrophage phenotypes in the neonatal gut that predispose premature infants to inflammatory injuries.
  • Preventive Therapies: Currently developing novel cytokine-based therapies to prevent NEC in extremely low birth weight infants.

Awards and Recognition

  • E. Mead Johnson Award (Nominee expertise level recognition).
  • Multiple NIH R01 Grants for research on neonatal mucosal immunology.
  • Top Doctors recognition in Neonatology.

Legacy

Dr. Maheshwari has mentored over 50 fellows and junior faculty, many of whom now hold leadership positions globally. His 200+ peer-reviewed publications form the bedrock of modern neonatal gastroenterology.

Affiliations & Institutions

Research Impact

5 Publications
0 Total Citations

Published In

Clin PerinatolCell RepNewborn (Clarksville)Curr Pediatr Rev

Areas of Expertise

Pioneering Techniques

Cytokine therapies for NECMacrophage phenotype identification

Media Archive

Portrait of Akhil Maheshwari
Feature Portrait